Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.
She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.
Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.
Dr. Irina Zaidman specializes in pediatric bone marrow transplantation – a critical treatment for aplastic anemia – at Hadassah Medical Center.
Performed over 3,500 bone marrow transplants – recognized by Forbes as one of the best doctors in 2018.
Professor Bosch is a world-renowned leader in Chronic Lymphocytic Leukemia (CLL), with over 100 published articles and ongoing participation in 80+ clinical trials.
Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.
She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.
Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.
Prof. Dr. Serdar Bedii Omay has published 65+ scientific articles on hematology – focused on advanced treatments at Emsey Hospital.
Dr. Apak specializes in pediatric hematology-oncology with 26 years of experience of experience, focusing on bone marrow transplantation and CAR T-cell therapy at Biruni University Hospital.
Associate Professor Rafet Eren specializes in hematology with 50+ publications in international journals, reflecting deep expertise in blood disorders.
Prof. Fabio Ciceri leads the Hematology and Bone Marrow Transplantation Unit at San Raffaele Research Hospital – a center specializing in advanced therapies for blood disorders.
Prof. Baytan specializes in pediatric hematology and oncology, with a focus on childhood cancers and bone marrow transplantations at Emsey Hospital.
Specializing in chronic leukemia and myeloproliferative diseases, Dr. Dogu brings extensive hematology expertise to Liv Hospital Ulus.
Associate Professor Ali Hakan Kaya specializes in hematology and stem cell transplants, with extensive training at top Turkish hospitals.
Dr. Eduardo Fernandez is one of only 50 certified stem cell experts in Mexico, recognized for his advanced knowledge in regenerative medicine.
Specializing in bone marrow failure disorders, Dr. Itir Sirinoglu Temiz leads the hematology department at Liv Hospital Vadistanbul.
Over 32 years of experience specializing in pediatric hematology – Dr. López-Ibor leads the Pediatric Hematology and Oncology Unit at HM Montepríncipe.